The latest health news
January 31 is set to mark the start of a watershed year for the biosimilars industry with the release of Amjevita, the first biosimilar for Humira, the world’s best-selling drug. …
Read More
The Covid-19 pandemic exposed a serious flaw in the United States’ medical supply chain: an overreliance on imported supplies. Reinvigorating a domestic supply chain is an important step toward protecting …
Read More
Editor’s note: A livestream of the event is embedded below. Like approaching asteroids, major biosimilars for Humira and other drugs are finally due to hit the market in 2023. Should …
Read More
Market share is often held up as the most relevant metric for the success of a biosimilar class. I believe there are other metrics, like cost savings or signs of …
Read More
Much of the current drug-pricing agenda proposed by President Biden and by Congress is based on the belief that greater government control — rather than free market competition — is …
Read More
I recently tried to order white blood cell growth factor (pegfilgrastim) biosimilar for one of my patients. This is a drug that helps prevent fever and infection associated with low …
Read More
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Biosimilars were anticipated to be a solution to the soaring cost of prescription medicines to …
Read More
It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain and digestion problems, fatigue and hot, red rashes. But even after learning in 2016 …
Read More
The Food and Drug Administration’s decision on Wednesday to approve a long-acting insulin called Semglee (insulin glargine-yfgn) as the first interchangeable biologic licensed for the U.S. market represents a major …
Read More